410.542.4470

A new Discern white paper, titled “Medical Technology in the Value-Based Environment: An Assessment of Quality Measure Gaps” and sponsored by the Advanced Medical Technology Association (AdvaMed), discusses the lack of adequate quality measures to effectively assess the value of medical technologies. The white paper identifies quality measurement opportunities and measure gaps for eight combinations of technologies and clinical areas. The paper outlines several steps that stakeholders—payers, providers, patients, manufacturers, and others— should take to fill quality measure gaps for medical technology. “An important takeaway from our findings is that value-based payment models do not adequately account for patient preference in selecting and using medical technology,” notes Discern Health Partner Tom Valuck, MD, JD.

Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the movement from vol...Learn More